California Peptide Research产品代理

California Peptide Research产品代理

简要描述:California Peptide Research提供客户的多肽合成定制服务,包括肥胖抑制素, β淀粉样肾脏髓质素肽, 内皮素, 内皮素拮抗剂。

详细介绍

产品咨询

California Peptide Research提供客户的多肽合成定制服务,包括肥胖抑制素, β淀粉样肾脏髓质素肽, 内皮素, 内皮素拮抗剂。

a-Secretase Substrate 1.0 mg 165
Acetyl-Arg-(Glu-Edans)-Val-His-His-Gln-Lys-Leu-Val-Phe-(Dabcyl-Lys)-Arg-OH
a-Secretase Substrate 5.0 mg 655
Acetyl-Arg-(Glu-Edans)-Val-His-His-Gln-Lys-Leu-Val-Phe-(Dabcyl-Lys)-Arg-OH
Abarelix 1.0 mg 130
Acetyl-(D-Naphtyl-Ala )-(p-Chloro-D-Phenylalanine)-(Pyridyl-Ala)-Ser-(NMe-Tyr)-D-Asp-Leu-(Iso-Lys)-Pro-D-Ala-NH2
Abarelix 5.0 mg 530
Acetyl-(D-Naphtyl-Ala )-(p-Chloro-D-Phenylalanine)-(Pyridyl-Ala)-Ser-(NMe-Tyr)-D-Asp-Leu-(Iso-Lys)-Pro-D-Ala-NH2
Ac-Arg-Ala-Arg-AMC 5.0 mg 125
Acetyl-Arg-Ala-Arg-AMC
Acetyl Beta Amyloid (25-35) 1.0 mg 55
Acetyl-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH
Acetyl Beta Amyloid (25-35) 5.0 mg 205
Acetyl-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH
Acetyl-Ala-Arg-AMC 10.0 mg 110
Acetyl-Ala-Arg-AMC
Acetyl-Arg-Ala-Val-AMC 5.0 mg 110
Acetyl-Arg-Ala-Val-AMC
Acetyl-Arg-Glu-Lys-Arg-AFC 5.0 mg 120
Acetyl-Arg-Glu-Lys-Arg-AFC
Acetyl-Arg-Gly-Phe-Phe-Pro-AFC 5.0 mg 140
Acetyl-Arg-Gly-Phe-Phe-Pro-AFC
Acetyl-Arg-Gly-Phe-Phe-Pro-AMC 5.0 mg 110
Acetyl-Arg-Gly-Phe-Phe-Pro-AMC
Acetyl-Arg-Ser-Leu-Lys-AMC 5.0 mg 110
Acetyl-Arg-Ser-Leu-Lys-AMC
Acetyl-Glu-Val-Asn-Leu-AFC 5.0 mg 120
Acetyl-Glu-Val-Asn-Leu-AFC
Acetyl-Glu-Val-Asn-Leu-AMC 5.0 mg 110
Acetyl-Glu-Val-Asn-Leu-AMC
Acetyl-Glu-Val-Asn-Leu-pNA 5.0 mg 90
Acetyl-Glu-Val-Asn-Leu-pNA
Acetyl-Leu-Gln-Thr-Asp-AFC 5.0 mg 120
Acetyl-Leu-Gln-Thr-Asp-AFC
Acetyl-Leu-Leu-Arg-AMC 5.0 mg 110
Acetyl-Leu-Leu-Arg-AMC
Acetyl-Leu-Leu-Leu-AFC 5.0 mg 120
Acetyl-Leu-Leu-Leu-AFC
Acetyl-Lys-Gln-Lys-Leu-Arg-4-methoxy-2-naphtylamide 5.0 mg 120
Acetyl-Lys-Gln-Lys-Leu-Arg-4-methoxy-2-naphtylamide
Acetyl-Lys-Pro-Arg-AFC 5.0 mg 120
Acetyl-Lys-Pro-Arg-AFC
Acetyl-Lys-Pro-Arg-AMC 5.0 mg 110
Acetyl-Lys-Pro-Arg-AMC
Acetyl-Neurotensin (8-13) 1.0 mg 35
Acetyl-Arg-Arg-Pro-Tyr-Ile-Leu-OH
Acetyl-Neurotensin (8-13) 5.0 mg 105
Acetyl-Arg-Arg-Pro-Tyr-Ile-Leu-OH
Acetyl-Phe-Ile-Pro-Ala-Ser-Leu-Arg-AFC 5.0 mg 150
Acetyl-Phe-Ile-Pro-Ala-Ser-Leu-Arg-AFC
Acetyl-Phe-Ser-Arg-pNA 5.0 mg 90
Acetyl-Phe-Ser-Arg-pNA
Acetyl-Pro-Glu-Asp-Glu-AFC 5.0 mg 120
Acetyl-Pro-Glu-Asp-Glu-AFC
Acetyl-Pro-Leu-Ser-Ser-Ile-Phe-Ser-Arg-Ile-Gly-Asp-Pro-Arg-Lys-Gly-Asp-Glu-Val-Asp-AFC 5.0 mg 185
Acetyl-Pro-Leu-Ser-Ser-Ile-Phe-Ser-Arg-Ile-Gly-Asp-Pro-Arg-Lys-Gly-Asp-Glu-Val-Asp-AFC
Acetyl-Ser-Asp-Lys-Pro 5.0 mg 35
Acetyl-Ser-Asp-Lys-Pro
Acetyl-Val-Glu-Ile-Ala-AFC 5.0 mg 120
Acetyl-Val-Glu-Ile-Ala-AFC
ACTH (1-17) human 1.0 mg 80
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-OH
ACTH (1-17) human 5.0 mg 315
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-OH
ACTH (1-24), human 1.0 mg 80
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH
ACTH (1-24), human 5.0 mg 315
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH
ACTH (1-39), rat 1.0 mg 205
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe-OH
ACTH (7-38), human / Corticotropin Inhibiting Peptide (7-38) 1.0 mg 120
Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-OH
ACTH (7-38), human / Corticotropin Inhibiting Peptide (7-38) 5.0 mg 485
Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-OH
ADAM substrate 1.0 mg 230
(Glu-EDANS)-Lys-Pro-Ala-Lys-Phe-Phe-Arg-Leu-(Dabcyl-Lys)-NH2
ADAM substrate 5.0 mg 895
(Glu-EDANS)-Lys-Pro-Ala-Lys-Phe-Phe-Arg-Leu-(Dabcyl-Lys)-NH2
Adamantaneacetyl-[DArg0,Hyp3,Thi5,8,DPhe7] Bradykinin 1.0 mg 60
Adamataneacetyl-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Phe-Thi-Arg-OH
Adamantaneacetyl-[DArg0,Hyp3,Thi5,8,DPhe7] Bradykinin 5.0 mg 210
Adamataneacetyl-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Phe-Thi-Arg-OH
Adrenal Secretogranin, bovine 5.0 mg 155
Phe-Pro-Lys-Pro-Ala-Gly-Ser-Gln-Asp-Lys-Pro-Leu-His-Asn-OH
Adrenomedullin (1-50), rat 0.5 mg 310
Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2
Adrenomedullin (1-50), rat 1.0 mg 500
Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2
Adrenomedullin (1-52), human 0.5 mg 310
Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2
Adrenomedullin (1-52), human 1.0 mg 500
Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2
Adrenomedullin (11-50), rat 0.5 mg 230
Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2
Adrenomedullin (11-50), rat 1.0 mg 395
Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2
Adrenomedullin (22-52), human 0.5 mg 160
Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2
Adrenomedullin (22-52), human 1.0 mg 240
Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2
Agatoxin IVa ( SS Cys 4,20 / Cys 12,25 / Cys 19,36 / Cys 27 0.5 mg 835
Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cys-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-Gly-Cys-Ile-Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-Leu-Ala-OH
Agatoxin IVa ( SS Cys 4,20 / Cys 12,25 / Cys 19,36 / Cys 27 1.0 mg 1525
Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cys-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-Gly-Cys-Ile-Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-Leu-Ala-OH
Akt Substrate 5.0 mg 105
Arg-Pro-Arg-Ala-Ala-Thr-Phe-NH2
All D Beta Amyloid (1-40), human 0.5 mg 395
D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gln-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val-D-Val-OH
All D Beta Amyloid (1-40), human 1.0 mg 685
D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gln-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val-D-Val-OH
Allatostatin B2, cockroach 1.0 mg 105
Ala-Tyr-Ser-Tyr-Val-Ser-Glu-Tyr-Lys-Arg-Leu-Pro-Val-Tyr-Asn-Phe-Gly-Leu-NH2
Alpha Atrial Natriuretic Polypeptide (1-28), human / ANP (1- 0.5 mg 125
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH
Alpha Atrial Natriuretic Polypeptide (1-28), human / ANP (1- 1.0 mg 205
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH
Alpha MSH Ac-Nle4 c[Asp5, D-Phe7, Lys10] (4-10) amide 1.0 mg 60
Acetyl-050-Asp-His-011-Arg-Trp-Lys-NH2
Alpha MSH Ac-Nle4 c[Asp5, D-Phe7, Lys10] (4-10) amide 5.0 mg 215
Acetyl-050-Asp-His-011-Arg-Trp-Lys-NH2
Alpha MSH [D-Phe7]

1.0 mg 60
Acetyl-Ser-Tyr-Ser-Met-Glu-His-011-Arg-Trp-Gly-Lys-Pro-Val-NH2
Alpha MSH [D-Phe7] 5.0 mg 215
Acetyl-Ser-Tyr-Ser-Met-Glu-His-011-Arg-Trp-Gly-Lys-Pro-Val-NH2
Alpha MSH [Nle4,D-Phe7] 1.0 mg 60
Acetyl-Ser-Tyr-Ser-050-Glu-His-011-Arg-Trp-Gly-Lys-Pro-Val-NH2
Alpha MSH [Nle4,D-Phe7] 5.0 mg 215
Acetyl-Ser-Tyr-Ser-050-Glu-His-011-Arg-Trp-Gly-Lys-Pro-Val-NH2
Alpha MSH, Ac-NLe4c[Asp5,DNal7,Lys10](4-10) amide 1.0 mg 60
Acetyl-050-Asp-His-038-Arg-Trp-Lys-NH2
Alpha MSH, Ac-NLe4c[Asp5,DNal7,Lys10](4-10) amide 5.0 mg 215
Acetyl-050-Asp-His-038-Arg-Trp-Lys-NH2
Amylin (1-37) NH2, human / Islet Amyloid Polypeptide (IAPP), 1.0 mg 295
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2
Amylin (1-37) NH2, human / Islet Amyloid Polypeptide (IAPP), 5.0 mg 1315
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2
Amylin (1-37) NH2, human / Islet Amyloid Polypeptide (IAPP), 10.0 mg 2520
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2
Amylin, rat 0.5 mg 135
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2
Amylin, rat 1.0 mg 230
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2
Amyloid Blocker 5.0 mg 85
Acetyl-Gln-Lys-Leu-Val-Phe-Phe-NH2
Amyloid fragment (Pro18,Asp21) (17-21) 5.0 mg 105
Leu-Pro-Phe-Phe-Asp-OH
Amyloid precursor 1.0 mg 135
Mca-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-(DNP-Lys)-Arg-Arg-NH2
Amyloid precursor 5.0 mg 525
Mca-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-(DNP-Lys)-Arg-Arg-NH2
Angiotensin Fragment ( 1-7 ) Acetate 5.0 mg 55
Asp-Arg-Val-Tyr-Ile-His-Pro-OH
Angiotensin I [Asn1,Val5,Asn9], salmon 1.0 mg 30
Asn-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH
Angiotensin I [Asn1,Val5,Asn9], salmon 5.0 mg 105
Asn-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH
Angiotensin I [Val5,Asn9], bullfrog 1.0 mg 30
Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH
Angiotensin I [Val5,Asn9], bullfrog 5.0 mg 105
Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH
Angiotensin I/II (1-5) 1.0 mg 45
Asp-Arg-Val-Tyr-Ile-OH
Angiotensin II [Sar1,Ile8] 1.0 mg 30
034-Arg-Val-Tyr-Ile-His-Pro-Ile-OH
Angiotensin II [Sar1,Ile8] 5.0 mg 100
034-Arg-Val-Tyr-Ile-His-Pro-Ile-OH
Angiotensin II, human 5.0 mg 35
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH
Angiotensin II-[Sar1] 5.0 mg 80
034-Arg-Val-Tyr-Ile-His-Pro-Phe-OH
Angiotensin III, human) / Angiotensin II-[Des Asp1] 10.0 mg 55
Arg-Val-Tyr-Ile-His-Pro-Phe-OH
Angiotensinogen (1-14) Renin Substrate (porcine) 1.0 mg 40
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH
Angiotensinogen (1-14) Renin Substrate (porcine) 10.0 mg 185
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser-OH
ANP (123-150), rat / ANP (6-33), rat / ANP (1-28), rat 0.5 mg 125
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH
ANP (123-150), rat / ANP (6-33), rat / ANP (1-28), rat 1.0 mg 205
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH
ANP (126-150), rat / Auriculin B, ANP (4-28), rat 0.5 mg 125
Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH
ANP (126-150), rat / Auriculin B, ANP (4-28), rat 1.0 mg 205
Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH
ANP (4-24), frog 1.0 mg 165
Cys-Phe-Gly-Ser-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Met-Gly-Cys-Gly-Arg-Arg-Phe-OH
ANP Des[18-22] (4-23) amide, rat 1.0 mg 125
Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Cys-NH2
Antennapedia Peptide 1.0 mg 80
Arg – Gln – Ile – Lys – Ile – Trp – Phe – Gln – Asn – Arg – Arg – Met – Lys – Trp – Lys – Lys
Apamin, bee venom (SS1-11)(SS3-15) 0.5 mg 105
Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-Arg-Cys-Gln-Gln-His-NH2
Apamin, bee venom (SS1-11)(SS3-15) 1.0 mg 160
Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-Arg-Cys-Gln-Gln-His-NH2
APP (354-371) 1.0 mg 135
Lys-Ala-Val-Ile-Gln-His-Phe-Gln-Glu-Lys-Val-Glu-Ser-Leu-Glu-Gln-Glu-Ala-OH
APP (354-371) 5.0 mg 525
Lys-Ala-Val-Ile-Gln-His-Phe-Gln-Glu-Lys-Val-Glu-Ser-Leu-Glu-Gln-Glu-Ala-OH
APP Beta Secretase Inhibitor 1.0 mg 160
Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-200-Val-Ala-Glu-Phe-OH
APP gamma secretase inhibitor 5.0 mg 60
3-5 difluorophenacetyl-Ala-217-t-Butylester
APP gamma secretase inhibitor 5.0 mg 60
3-5 difluorophenacetyl-Ala-(S-Phenylglycine)-Methylester
Arg-Glu(EDANS)-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-(e-Dabcyl-Lysine)-Arg-OH 1.0 mg 135
Arg-Glu(EDANS)-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-(e-Dabcyl-Lysine)-Arg-OH
Arg-Leu-Lys-Gly-Gly-AFC 5.0 mg 140
Arg-Leu-Lys-Gly-Gly-AFC
Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln-OH 5.0 mg 120
Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln-OH
Asp-Glu-Val-Asp-AFC 5.0 mg 120
Asp-Glu-Val-Asp-AFC
Atriopeptine III, rat;ANP (127-150), rat 0.5 mg 115
Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH
Atriopeptine III, rat;ANP (127-150), rat 1.0 mg 185
Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH
Autocamptide-2 Related Inhibitoy Peptide 5.0 mg 105
Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Ala-Val-Asp-Ala-Leu-OH
Autocamptide-2 Related Inhibitoy Peptide 5.0 mg 105
Myristoyl-Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Ala-Val-Asp-Ala-Leu-OH
BAM (6-22) Quote : 6920 0.5 mg 125
Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH
BAM (6-22) Quote : 6920 1.0 mg 185
Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH
BAM 3200 Bovine Adrenal Medulla Peptide E 0.5 mg 175
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-Gly-Phe-Leu-OH
BAM 3200 Bovine Adrenal Medulla Peptide E 1.0 mg 290
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-Gly-Phe-Leu-OH
Beta Amyloid (1-16) [Gln11], human 0.5 mg 60
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-OH
Beta Amyloid (1-16) [Gln11], human 1.0 mg 85
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-OH
Beta Amyloid (1-16) [Gln11], human 5.0 mg 320
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-OH
Beta Amyloid (1-16), rat 1.0 mg 90
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-OH
Beta Amyloid (1-16), rat 5.0 mg 340
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-OH
Beta Amyloid (1-28), [Gln11], human 0.5 mg 95
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH

California-Bioscience代理

California-Bioscience代理

简要描述:California-Bioscience 代理,California-Bioscience 上海代理,California-Bioscience 北京代理, California-Bioscience 代理,California-Bioscience代理
上海金畔生物科技有限公司 California-Bioscience 专业代理,具体产品信息欢迎电询:021-50837765

详细介绍

产品咨询

世界*实验材料供应商 California-Bioscience上海金畔生物为其中国代理, California-Bioscience在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品,的服务, California-Bioscience就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

 California-Bioscience中国代理, California-Bioscience 上海代理, California-Bioscience北京代理,California-Bioscience广东代理, California-Bioscience江苏代理California-Bioscience湖北代理,California-Bioscience天津,California-Bioscience  黑龙江代理,California-Bioscience 内蒙古代理,California-Bioscience吉林代理,California-Bioscience福建代理, California-Bioscience江苏代理, California-Bioscience浙江代理, California-Bioscience四川代理,

 

California-Bioscience(简称Cali-Bio)坐落于美国加州,是世界上规模zui大的重组蛋白生产商。Cali-Bio专注于大肠杆菌、昆虫或哺乳动物细胞表达重组蛋白,为多家著名的细胞因子供应商提供产品。

Cali-Bio产品涉及人、小鼠、大鼠、猪及牛等物种的细胞因子、生长因子、趋化因子、蛋白激酶以及病毒抗原等。所有蛋白均经过严格的质量检测,可应用于肿瘤、凋亡、发育、免疫、神经科学、干细胞等研究领域。

 

 

上海金畔生物科技有限公司

核酸多肽蛋白标记 California Red SE 货号479-AAT Bioquest荧光染料

上海金畔生物科技有限公司代理AAT Bioquest荧光染料全线产品,欢迎访问AAT Bioquest荧光染料官网了解更多信息。

核酸多肽蛋白标记 California Red SE

核酸多肽蛋白标记 California Red SE

核酸多肽蛋白标记 California Red SE     货号479 货号 479 存储条件 在零下15度以下保存, 避免光照
规格 1 mg 价格 1272
Ex (nm) 592 Em (nm) 609
分子量 814.92 溶剂 DMSO
产品详细介绍

简要概述

产品基本信息

货号:479

产品名称:核酸多肽蛋白标记 California Red SE 

规格:1mg

储存条件:-15℃,避光干燥

保质期:12个月

 

物理化学光谱特性

分子量:814.92

溶剂:DMSO

Ex(nm):583

Em(nm):603

 

产品介绍

核酸多肽蛋白标记 California Red SE 是美国AAT Bioquest生产的核酸染料,TexasRed®它在水中非常不稳定。 即使在无水DMF中,TexasRed®也会产生非常复杂的反应混合物。 它不加区别地与硫醇,醇,酚,脂族胺和芳香胺反应。 California Red 是一种琥珀酰亚胺酯,其光谱特性与TexasRed®相同,California Red 是TexasRed®的优质替代品。 California Red 仅与脂肪胺(如氨基酸,多肽和蛋白质)发生反应,生成极稳定的亮红色荧光结合物。 与TexasRed®相比,California Red具有更高的标记效率,而且所得缀合物更容易被纯化。金畔生物是AAT Bioquest的中国代理商,为您提供优质的核酸多肽蛋白标记 California Red SE 。   

点击查看光谱

 

参考文献

A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery
Authors: Garcia-Fuentes M, Prego C, Torres D, Alonso MJ.
Journal: Eur J Pharm Sci (2005): 133

Bead-based cellular analysis, sorting and multiplexing
Authors: Sanchez-Martin RM, Muzerelle M, Chitkul N, How SE, Mittoo S, Bradley M.
Journal: Chembiochem (2005): 1341

Budding dynamics of multicomponent tubular vesicles
Authors: Li L, Liang X, Lin M, Qiu F, Yang Y.
Journal: J Am Chem Soc (2005): 17996

Emission characteristics of fluorescent labels with respect to temperature changes and subsequent effects on DNA microchip studies
Authors: Liu WT, Wu JH, Li ES, Selamat ES.
Journal: Appl Environ Microbiol (2005): 6453

Fluorescence properties of fluorescein, tetramethylrhodamine and Texas Red linked to a DNA aptamer
Authors: Unruh JR, Gokulrangan G, Wilson GS, Johnson CK.
Journal: Photochem Photobiol (2005): 682

Orientational dynamics and dye-DNA interactions in a dye-labeled DNA aptamer
Authors: Unruh JR, Gokulrangan G, Lushington GH, Johnson CK, Wilson GS.
Journal: Biophys J (2005): 3455

Purification and fluorescent labeling of the human serotonin transporter
Authors: Rasmussen SG, Gether U.
Journal: Biochemistry (2005): 3494

Transepithelial transport of fluorescent p-glycoprotein and MRP2 substrates by insect Malpighian tubules: confocal microscopic analysis of secreted fluid droplets
Authors: Leader JP, O’Donnell MJ.
Journal: J Exp Biol (2005): 4363

Measurement of normal and anomalous diffusion of dyes within protein structures fabricated via multiphoton excited cross-linking
Authors: Basu S, Wolgemuth CW, Campagnola PJ.
Journal: Biomacromolecules (2004): 2347

Multistep fluorescence resonance energy transfer in sequential chromophore array constructed on oligo-DNA assemblies
Authors: Ohya Y, Yabuki K, Hashimoto M, Nakajima A, Ouchi T.
Journal: Bioconjug Chem (2003): 1057

说明书
核酸多肽蛋白标记 California Red SE .pdf